Slate Medicines
Advancing anti-PACAP therapies for the prevention of migraine and other headache disorders.
About
Technology stack
detected 2026-06-17No comments yet. Be the first to share your take.
What does Slate Medicines do?
Slate Medicines is a biotechnology company focused on developing novel anti-PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) therapies for the prevention and treatment of migraine and other severe headache disorders. The company launched with a significant Series A financing to support its therapeutic pipeline.
How much funding has Slate Medicines raised?
Slate Medicines has raised a total of $130M in funding. The most recent round on record is Series A.
Where is Slate Medicines headquartered?
Slate Medicines is headquartered in Cambridge, Massachusetts, United States.
When was Slate Medicines founded?
Slate Medicines was founded in 2024.
What industry does Slate Medicines operate in?
Slate Medicines operates in Biotechnology, Pharmaceuticals, Therapeutics, Healthcare.